• Business
  • Markets
  • Politics
  • Crypto
  • Finance
  • Intelligence
    • Policy Intelligence
    • Security Intelligence
    • Economic Intelligence
    • Fashion Intelligence
  • Energy
  • Technology
  • Taxes
  • Creator Economy
  • Wealth Management
  • LBNN Blueprints
  • Business
  • Markets
  • Politics
  • Crypto
  • Finance
  • Intelligence
    • Policy Intelligence
    • Security Intelligence
    • Economic Intelligence
    • Fashion Intelligence
  • Energy
  • Technology
  • Taxes
  • Creator Economy
  • Wealth Management
  • LBNN Blueprints

Bristol Myers says next-gen blood cancer drug hits goal in key study

Simon Osuji by Simon Osuji
September 23, 2025
in Technology
0
Bristol Myers says next-gen blood cancer drug hits goal in key study
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

The drug, iberdomide, is one of a few protein-degrading medicines the company hopes to become successors to its blockbuster Revlimid franchise.

Related posts

Sanofi, looking for more ‘rigor,’ swaps CEO Hudson for ex-Merck KGaA chief Garijo

Sanofi, looking for more ‘rigor,’ swaps CEO Hudson for ex-Merck KGaA chief Garijo

February 12, 2026
Eyesan urges global investors to seize opportunities in 2025 Licensing Round – EnviroNews

Eyesan urges global investors to seize opportunities in 2025 Licensing Round – EnviroNews

February 12, 2026

Source link

Previous Post

Patensie songbird wins Agri’s Got Talent 2025

 Next Post

PROTEUS-6G Transforms Optical Networks – Telecom Review Africa
Next Post
PROTEUS-6G Transforms Optical Networks – Telecom Review Africa

PROTEUS-6G Transforms Optical Networks - Telecom Review Africa

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

RECOMMENDED NEWS

You Can Now Snag a Specialized Electric Bike for $2,000

You Can Now Snag a Specialized Electric Bike for $2,000

2 years ago
Syria, Jordan sign gas supply deal to bolster Syrian power grid

Syria, Jordan sign gas supply deal to bolster Syrian power grid

2 weeks ago
Buy Now Ahead of October, Expert Analyst Signals Surge

Buy Now Ahead of October, Expert Analyst Signals Surge

6 months ago
Novartis wagers billions of dollars on PTC Huntington’s drug

FDA broadens use of Novartis’ radiopharma drug Pluvicto

11 months ago

POPULAR NEWS

  • Ghana to build three oil refineries, five petrochemical plants in energy sector overhaul

    Ghana to build three oil refineries, five petrochemical plants in energy sector overhaul

    0 shares
    Share 0 Tweet 0

  • The world’s top 10 most valuable car brands in 2025

    0 shares
    Share 0 Tweet 0

  • Top 10 African countries with the highest GDP per capita in 2025

    0 shares
    Share 0 Tweet 0

  • Global ranking of Top 5 smartphone brands in Q3, 2024

    0 shares
    Share 0 Tweet 0

  • When Will SHIB Reach $1? Here’s What ChatGPT Says

    0 shares
    Share 0 Tweet 0

Get strategic intelligence you won’t find anywhere else. Subscribe to the Limitless Beliefs Newsletter for monthly insights on overlooked business opportunities across Africa.

Subscription Form

© 2026 LBNN – All rights reserved.

Privacy Policy | About Us | Contact

Tiktok Youtube Telegram Instagram Linkedin X-twitter
No Result
View All Result
  • Home
  • Business
  • Politics
  • Markets
  • Crypto
  • Economics
    • Manufacturing
    • Real Estate
    • Infrastructure
  • Finance
  • Energy
  • Creator Economy
  • Wealth Management
  • Taxes
  • Telecoms
  • Military & Defense
  • Careers
  • Technology
  • Artificial Intelligence
  • Investigative journalism
  • Art & Culture
  • LBNN Blueprints
  • Quizzes
    • Enneagram quiz
  • Fashion Intelligence

© 2023 LBNN - All rights reserved.